RemeGen is a global biopharmaceutical company, focusing on the discovery, development and commercialization of novel biologics for the treatment of autoimmune, oncology and ophthalmic diseases with significant unmet medical needs. RemeGen Biosciences, a wholly owned subsidiary of RemeGen, is based in South San Francisco, California, the birthplace of biotechnology and in Maryland. Our vision is to create the first-in-class and/or best-in-class biotherapeutics with innovative target discovery strategies, advanced molecule design and protein engineering platforms. Our passion is to serve patients with more effective therapies in a timely manner.

Biotechnology

Life Sciences

Therapeutics

RemeGen Biosciences

Zhulun Wang

Yiying Khor

Michelle Fang

Kevin Wait

Hang Chen

Clinical Development Team

Leadership Team

Teams at RemeGen Biosciences

Clinical Development Team

Leadership Team